Serotonin transporter inhibition and 5-HT2C receptor activation drive loss of cocaine-induced locomotor activation in DAT Val559 mice
Stewart A, Davis G, Gresch P, Katamish R, Peart R, Rabil M, Gowrishankar R, Carroll F, Hahn M, Blakely R. Serotonin transporter inhibition and 5-HT2C receptor activation drive loss of cocaine-induced locomotor activation in DAT Val559 mice. Neuropsychopharmacology 2018, 44: 994-1006. PMID: 30578419, PMCID: PMC6462012, DOI: 10.1038/s41386-018-0301-8.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsBehavior, AnimalCocaineConditioning, ClassicalDisease Models, AnimalDopamineDopamine Plasma Membrane Transport ProteinsDopamine Uptake InhibitorsFluoxetineLocomotionMethylphenidateMiceMice, 129 StrainMice, Inbred C57BLMice, TransgenicNeostriatumReceptor, Serotonin, 5-HT2CSelective Serotonin Reuptake InhibitorsSerotonin Plasma Membrane Transport ProteinsConceptsSerotonin (5-HT) transporterAttention-deficit/hyperactivity disorderConditioned place preferenceDA transporterLocomotor activityExtracellular DACocaine-induced locomotor activityElevation of extracellular DACocaine-induced elevationsCocaine-induced hyperlocomotionCocaine-induced locomotionElevated extracellular DAStriatal DA releaseSerotonin transporter inhibitionPlace preferenceRTI-113Cocaine actionCocaine interactionsWaiting impulsivityCocaine administrationLocomotor effectsDA releaseSerotonergic plasticityCocaine analogsAttention-deficit/hyperactivity
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply